An Improved Extended-Spectrum-β-Lactamase Detection Test Utilizing Aztreonam plus Clavulanate

Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-Analysis

(2017) Myrto Eleni Flokas et al.   PLoS One

Lowering of Third Generation Cephalosporin Breakpoints

(2013) K. S. Thomson   CLINICAL INFECTIOUS DISEASES

Background and Rationale for Revised Clinical and Laboratory Standards Institute Interpretive Criteria (Breakpoints) for Enterobacteriaceae andPseudomonas aeruginosa:I. Cephalosporins and Aztreonam

(2013) Michael N. Dudley et al.   CLINICAL INFECTIOUS DISEASES

Commentary

(2013) Michael N. Dudley et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Prevalence and Molecular Characterization of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in a Pediatric Patient Population

(2012) Lakshmi Chandramohan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comment on: Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

(2012) J. Kavi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

(2012) D. M. Livermore et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Detection of Extended-Spectrum β-Lactamase in Enterobacter spp.– Evaluation of Six Phenotypic Tests

(2011) Keite da Silva Nogueira-Miranda et al.   Microbial Drug Resistance

Bacteremia Due to Extended-Spectrum- -Lactamase-Producing Enterobacter cloacae: Role of Carbapenem Therapy

(2010) C.-C. Lee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Microbiologic and Clinical Implications of Bacteremia Due to Extended-Spectrum- -Lactamase-Producing Klebsiella pneumoniae with or without Plasmid-Mediated AmpC  -Lactamase DHA-1

(2010) C.-H. Lee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High frequency of  -lactam susceptibility in CTX-M-type extended-spectrum- -lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations

(2010) K. R. P. de Oliveira et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Extended-Spectrum- -Lactamase, AmpC, and Carbapenemase Issues

(2010) K. S. Thomson   JOURNAL OF CLINICAL MICROBIOLOGY

Broth Microdilution Method To Detect Extended-Spectrum  -Lactamases and AmpC  -Lactamases in Enterobacteriaceae Isolates by Use of Clavulanic Acid and Boronic Acid as Inhibitors

(2009) S. H. Jeong et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Detection of SHV-Type Extended-Spectrum Beta-Lactamase inEnterobacterIsolates : TABLE 1.

(2009) Trent G. Towne et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Breakpoints for intravenously used cephalosporins in Enterobacteriaceae—EUCAST and CLSI breakpoints

(2008) G. Kahlmeter   CLINICAL MICROBIOLOGY AND INFECTION

Prevalence and characterization of extended-spectrum β-lactamase–producing Enterobacteriaceae isolated in Korean hospitals

(2008) Kwan Soo Ko et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Boronic acid disk tests for identification of extended-spectrum β-lactamase production in clinical isolates of Enterobacteriaceae producing chromosomal AmpC β-lactamases

(2008) Seok Hoon Jeong et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria

(2008) H. Iabadene et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular typing and characterization of extended-spectrum TEM, SHV and CTX-M β-lactamases in clinical isolates of Enterobacter cloacae

(2008) Maurice Biendo et al.   RESEARCH IN MICROBIOLOGY